AMSTERDAM, 23 December 2019, 07:00 CET – Avantium, a leading technology company in renewable chemistry, announced today the appointment of Bart Welten as Chief Financial Officer (CFO). Mr. Welten will join Avantium in January 2020. The Supervisory Board proposes to appoint Mr. Welten as a statutory member of the Management Board of Avantium at the Annual General Meeting of Shareholders (AGM) of 14 May 2020.
Mr. Welten will bring 30 years of experience in finance to Avantium and has extensive knowledge of the chemical and life-sciences industries. He served as the CFO of Centrient Pharmaceuticals (formerly the joint-venture of DSM and Sinochem) in Singapore and managed the sale of the company to Bain Capital. Prior to this, Mr. Welten held the position of CFO of DSM Resins and DSM Anti-Infectives. He holds a law degree from Leiden University (Netherlands) and an MBA from Boston College (USA).
Tom van Aken, CEO of Avantium said: “We are delighted to welcome Bart to Avantium as our new CFO. He brings a wealth of international finance and managerial experience, and we are confident that he will make a very important contribution to Avantium and help enable us to delivering our strategic objectives.” “I am very pleased to join Avantium as CFO,” commented Bart Welten. “There is an increasing demand worldwide for innovative and sustainable technologies to help alleviate serious environmental problems such as climate change and plastic waste. Avantium is very well positioned to take the leading role in the transition to a renewable and circular chemical industry.”